Various bodies of evidence have shown that HDAC inhibitors effectively suppress inflammation in animal models of inflammatory diseases such as arthritis, asthma, diabetes, and cardiovascular diseases [52, 53]. Here, HDAC9 is linked to cardiovascular disorder.